Johns Hopkins All Children’s Hospital Becomes The 1st U.S Pediatric VTE Center of Excellence – NBCA
National Blood Clot Alliance shared a post on LinkedIn:
”A first for pediatric blood clot care in the U.S
The National Blood Clot Alliance is proud to name Johns Hopkins All Children’s Hospital the nation’s first Pediatric VTE Center of Excellence™.
This milestone sets a new national standard for how we prevent, diagnose, and treat blood clots in children.
Pediatric blood clots are often underrecognized – but the need for specialized, coordinated care is growing.
This designation reflects:
- Multidisciplinary, family-centered care.
- Standardized protocols and continuous improvement
- A strong focus on prevention and early recognition
‘Pediatric VTE presents unique clinical challenges… our focus is on prevention, timely diagnosis and coordinated, family-centered care.’ – Neil Goldenberg, MD, PhD
This is more than a designation – it’s a step forward in ensuring children receive the lifesaving care they deserve.”

Stay updated with Hemostasis Today.
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’